| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.5 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.5 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.048 | 0.5 |